ロード中...
Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples
INTRODUCTION –: ROS1 gene fusions are a well-characterized class of oncogenic driver found in approximately 1-2% of non-small cell lung cancer patients. ROS1-directed therapy in these patients is more efficacious and is associated with fewer side effects compared to chemotherapy and is thus now cons...
保存先:
| 出版年: | J Thorac Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286810/ https://ncbi.nlm.nih.gov/pubmed/29935306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2018.05.041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|